Literature DB >> 15823499

The immunobiology of primary sclerosing cholangitis.

Christopher A Aoki1, Christopher L Bowlus, M Eric Gershwin.   

Abstract

An understanding of the immunobiology of primary sclerosing cholangitis (PSC) is essential to improving both diagnosis and treatment. There have been significant gains in the discovery of genetic polymorphisms that generate susceptibility to disease, but only limited data on etiologic events that may initiate the inflammatory response. Colonic inflammation produces memory T cells that have the ability to bind both biliary and colonic endothelial cells. One possible mechanism for the development of PSC is the homing of these memory T cells to the biliary tree. In addition, TNF(alpha) may contribute to the oxidative damage of the biliary system. Finally, although speculative, mononuclear cell responses against biliary epithelial cells may create a persistent inflammatory response, eventually leading to fibrosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15823499     DOI: 10.1016/j.autrev.2004.09.003

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  21 in total

1.  Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis.

Authors:  Masanobu Tsuda; Yoko M Ambrosini; Weici Zhang; Guo-Xiang Yang; Yugo Ando; Guanghua Rong; Koichi Tsuneyama; Kosuke Sumida; Shinji Shimoda; Christopher L Bowlus; Patrick S C Leung; Xiao-Song He; Ross L Coppel; Aftab A Ansari; Zhe-Xiong Lian; M Eric Gershwin
Journal:  Hepatology       Date:  2011-10       Impact factor: 17.425

2.  The role of osteopontin and tumor necrosis factor alpha receptor-1 in xenobiotic-induced cholangitis and biliary fibrosis in mice.

Authors:  Peter Fickert; Andrea Thueringer; Tarek Moustafa; Dagmar Silbert; Judith Gumhold; Oleksiy Tsybrovskyy; Margitta Lebofsky; Hartmut Jaeschke; Helmut Denk; Michael Trauner
Journal:  Lab Invest       Date:  2010-04-05       Impact factor: 5.662

Review 3.  Latest and emerging therapies for primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Claudia O Zein; Keith D Lindor
Journal:  Curr Gastroenterol Rep       Date:  2010-02

4.  Cutting edge issues in primary sclerosing cholangitis.

Authors:  Christopher L Bowlus
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

5.  miR-221 suppresses ICAM-1 translation and regulates interferon-gamma-induced ICAM-1 expression in human cholangiocytes.

Authors:  Guoku Hu; Ai-Yu Gong; Jun Liu; Rui Zhou; Caishu Deng; Xian-Ming Chen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-01-28       Impact factor: 4.052

Review 6.  Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.

Authors:  María Rojas-Feria; Manuel Castro; Emilio Suárez; Javier Ampuero; Manuel Romero-Gómez
Journal:  World J Gastroenterol       Date:  2013-11-14       Impact factor: 5.742

Review 7.  Recurrence of autoimmune liver diseases after liver transplantation.

Authors:  Nabiha Faisal; Eberhard L Renner
Journal:  World J Hepatol       Date:  2015-12-18

Review 8.  Atypical p-ANCA in PSC and AIH: a hint toward a "leaky gut"?

Authors:  Birgit Terjung; Ulrich Spengler
Journal:  Clin Rev Allergy Immunol       Date:  2009-02       Impact factor: 8.667

Review 9.  Roles of infection, inflammation, and the immune system in cholesterol gallstone formation.

Authors:  Kirk J Maurer; Martin C Carey; James G Fox
Journal:  Gastroenterology       Date:  2008-12-25       Impact factor: 22.682

Review 10.  The immunobiology of primary sclerosing cholangitis.

Authors:  Jonathan H Aron; Christopher L Bowlus
Journal:  Semin Immunopathol       Date:  2009-05-26       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.